Research Summary
Dry eye syndrome, also known as keratoconjunctivitis sicca, is a common eye condition characterized by insufficient moisture and lubrication on the surface of the eyes. This occurs when the eyes either do not produce enough tears or when the tears evaporate too quickly. Dry eye syndrome can lead to discomfort, irritation, a gritty or sandy feeling in the eyes, redness, blurred vision, and sensitivity to light. It can be caused by various factors, including aging, environmental conditions, certain medications, hormonal changes, and underlying health conditions. Management of dry eye syndrome involves using artificial tears, warm compresses, lifestyle adjustments, and sometimes prescription medications, all aimed at relieving symptoms and improving the tear film stability to enhance eye comfort and health.
According to DIResearch's in-depth investigation and research, the global Dry Eye Syndrome market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Dry Eye Syndrome include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, SIMILASAN, URSAPHARM, Akorn, United Laboratories, Sun Pharmaceutical, Eusan etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Dry Eye Syndrome. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Dry Eye Syndrome market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Dry Eye Syndrome market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Dry Eye Syndrome industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Dry Eye Syndrome Include:
Allergan
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
SIMILASAN
URSAPHARM
Akorn
United Laboratories
Sun Pharmaceutical
Eusan
Dry Eye Syndrome Product Segment Include:
Artificial Tears
Anti-inflammatory Drugs
1.2.3 Other
Dry Eye Syndrome Product Application Include:
Hospital
Drug Stores
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Dry Eye Syndrome Industry PESTEL Analysis
Chapter 3: Global Dry Eye Syndrome Industry Porter's Five Forces Analysis
Chapter 4: Global Dry Eye Syndrome Major Regional Market Size and Forecast Analysis
Chapter 5: Global Dry Eye Syndrome Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Dry Eye Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Dry Eye Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Dry Eye Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Dry Eye Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Dry Eye Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Dry Eye Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Dry Eye Syndrome Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Dry Eye Syndrome Market Overview 1.1 Product Definition and Statistical Scope 1.2 Dry Eye Syndrome Product by Type 1.2.1 Global Dry Eye Syndrome Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Artificial Tears 1.2.3 Anti-inflammatory Drugs 1.2.4 1.2.3 Other 1.3 Dry Eye Syndrome Product by Application 1.3.1 Global Dry Eye Syndrome Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Hospital 1.3.3 Drug Stores 1.4 Global Dry Eye Syndrome Market Revenue Analysis (2019-2030) 1.5 Dry Eye Syndrome Market Development Status and Trends 1.5.1 Dry Eye Syndrome Industry Development Status Analysis 1.5.2 Dry Eye Syndrome Industry Development Trends Analysis 2 Dry Eye Syndrome Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Dry Eye Syndrome Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Dry Eye Syndrome Market Analysis by Regions 4.1 Dry Eye Syndrome Overall Market: 2023 VS 2024 VS 2030 4.2 Global Dry Eye Syndrome Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Dry Eye Syndrome Revenue and Market Share by Region (2019-2024) 4.2.2 Global Dry Eye Syndrome Revenue Forecast by Region (2025-2030) 5 Global Dry Eye Syndrome Market Size by Type and Application 5.1 Global Dry Eye Syndrome Market Size by Type 5.2 Global Dry Eye Syndrome Market Size by Application 6 North America 6.1 North America Dry Eye Syndrome Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Dry Eye Syndrome Market Size by Type 6.4 North America Dry Eye Syndrome Market Size by Application 6.5 North America Dry Eye Syndrome Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Dry Eye Syndrome Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Dry Eye Syndrome Market Size by Type 7.4 Europe Dry Eye Syndrome Market Size by Application 7.5 Europe Dry Eye Syndrome Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Dry Eye Syndrome Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Dry Eye Syndrome Market Size by Type 8.4 China Dry Eye Syndrome Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Dry Eye Syndrome Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Dry Eye Syndrome Market Size by Type 9.4 APAC (excl. China) Dry Eye Syndrome Market Size by Application 9.5 APAC (excl. China) Dry Eye Syndrome Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Dry Eye Syndrome Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Dry Eye Syndrome Market Size by Type 10.4 Latin America Dry Eye Syndrome Market Size by Application 10.5 Latin America Dry Eye Syndrome Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Dry Eye Syndrome Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Dry Eye Syndrome Market Size by Type 11.4 Middle East & Africa Dry Eye Syndrome Market Size by Application 11.5 Middle East & Africa Dry Eye Syndrome Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Dry Eye Syndrome Market Revenue by Key Manufacturers (2020-2024) 12.2 Dry Eye Syndrome Competitive Landscape Analysis and Market Dynamic 12.2.1 Dry Eye Syndrome Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Allergan 13.1.1 Allergan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Allergan Dry Eye Syndrome Product Portfolio 13.1.3 Allergan Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Alcon 13.2.1 Alcon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Alcon Dry Eye Syndrome Product Portfolio 13.2.3 Alcon Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Novartis 13.3.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Novartis Dry Eye Syndrome Product Portfolio 13.3.3 Novartis Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Santen Pharma 13.4.1 Santen Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Santen Pharma Dry Eye Syndrome Product Portfolio 13.4.3 Santen Pharma Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Johnson & Johnson 13.5.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Johnson & Johnson Dry Eye Syndrome Product Portfolio 13.5.3 Johnson & Johnson Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Bausch & Lomb 13.6.1 Bausch & Lomb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Bausch & Lomb Dry Eye Syndrome Product Portfolio 13.6.3 Bausch & Lomb Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Thea pharmaceuticals 13.7.1 Thea pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Thea pharmaceuticals Dry Eye Syndrome Product Portfolio 13.7.3 Thea pharmaceuticals Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 SIMILASAN 13.8.1 SIMILASAN Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 SIMILASAN Dry Eye Syndrome Product Portfolio 13.8.3 SIMILASAN Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 URSAPHARM 13.9.1 URSAPHARM Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 URSAPHARM Dry Eye Syndrome Product Portfolio 13.9.3 URSAPHARM Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Akorn 13.10.1 Akorn Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Akorn Dry Eye Syndrome Product Portfolio 13.10.3 Akorn Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 United Laboratories 13.11.1 United Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 United Laboratories Dry Eye Syndrome Product Portfolio 13.11.3 United Laboratories Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.12 Sun Pharmaceutical 13.12.1 Sun Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 Sun Pharmaceutical Dry Eye Syndrome Product Portfolio 13.12.3 Sun Pharmaceutical Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.13 Eusan 13.13.1 Eusan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Eusan Dry Eye Syndrome Product Portfolio 13.13.3 Eusan Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Dry Eye Syndrome Industry Chain Analysis 14.2 Dry Eye Syndrome Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Dry Eye Syndrome Typical Downstream Customers 14.4 Dry Eye Syndrome Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support